Altered systemic Adipokine levels in pulmonary tuberculosis and changes following treatment.

Kadar, M.; Kumar, N.P.; Nair, D.; Banurekha, V.V.; Babu, S .

The American Journal of Tropical Medicine and Hygiene; 2018; 99(4): 875-880.

Abstract: Pulmonary tuberculosis (PTB) is associated with modulation of levels of adipokines, speci?cally adiponectin and leptin, but the effect of standard antituberculosis treatment (ATT) on the systemic levels of adiponectin, resistin, and leptin has not been well explored. To identify the association of adipokines with PTB and their relationship with disease severity and bacterial burden, we measured the levels of adiponectin, resistin, and leptinin PTB individuals and compared them with latent tuberculosis (LTB) and healthy control (HC) individuals. Pulmonary tuberculosis was characterized by diminished circulating levels of adiponectin and leptin and heightened circulating levels of resistin in comparison to that in LTB and HC individuals. However, PTB with bilateralor cavitary disease did not exhibit any increased systemic levels of these adipokines in comparison with those with unilateral or non-cavitary disease, respectively. In addition, none of the adipokines exhibited a positive correlation with bacterial burdens, but adiponectinal one exhibited a negative correlation with body mass index in PTB individuals. Finally, on successful completion of ATT, PTB individuals exhibited signi?cantly increased levels of adiponectin and leptin and signi?cantly decreased levels of resistin. Therefore, our data identify an important association of systemic adipokine levels with PTB disease and its alteration following ATT.

Back to List of publications / Home